目次

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Treatment
1.1.2 Regional Scope
1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4

Chapter 2. Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3. End Stage Renal Disease Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Product Pipeline Analysis
3.4 User Perspective Analysis
3.4.1 Consumer Behavior Analysis
3.4.2 Market Influencer Analysis
3.5 List Of Key End Users
3.6 Regulatory Framework
3.7 Market Dynamics
3.7.1 Market Driver Analysis
3.7.1.1 Growing Prevalence Of Diabetes And Hypertension
3.7.1.2 Introduction Of Technologically Advanced Products
3.7.1.3 Increasing Number Of Patients Suffering From Chronic Kidney Disease
3.7.2 Market Restraints Analysis
3.7.2.1 Risk Of Complications
3.7.2.2 Stringent Regulatory Policies For Dialysis Products
3.8 End Stage Renal Disease: Market Analysis Tools
3.8.1 Industry Analysis - Porter’s
3.8.2 Swot Analysis, By Pest

Chapter 4. End Stage Renal Disease Market: Segment Analysis, By Treatment, 2018 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Treatment Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global End Stage Renal Disease Market, by Treatment, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 DIALYSIS
4.5.1.1 Dialysis market, 2018 - 2030 (USD Million)
4.5.2 TRANSPLANT
4.5.2.1 Transplant market, 2018 - 2030 (USD Million)

Chapter 5. End Stage Renal Disease Market: Regional Market Analysis, By Treatment, 2018 - 2030 (USD Million)
5.1 Definition & Scope
5.2 Regional Market Share Analysis, 2021 & 2030
5.3 Regional Market Dashboard
5.4 Regional Market Snapshot
5.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.5.1 North America
5.5.2 Europe
5.5.3 Asia Pacific
5.5.4 Latin America
5.5.5 Middle East and Africa
5.6 Market Size, & Forecasts, Volume and Trend Analysis, 2016 to 2030
5.7 North America
5.7.1 North America End Stage Renal Disease Market, 2018 - 2030 (USD Million)
5.7.2 U.S.
5.7.2.1 U.S. end-stage renal disease market, 2018 - 2030 (USD Million)
5.7.3 Canada
5.7.3.1 Canada end-stage renal disease market, 2018 - 2030 (USD Million)
5.8 Europe
5.8.1 Europe End Stage Renal Disease Market, 2018 - 2030 (USD Million)
5.8.2 U.K.
5.8.2.1 U.K. end-stage renal disease market, 2018 - 2030 (USD Million)
5.8.3 Germany
5.8.3.1 Germany end-stage renal disease market, 2018 - 2030 (USD Million)
5.8.4 France
5.8.4.1 France end-stage renal disease market, 2018 - 2030 (USD Million)
5.8.5 Italy
5.8.5.1 Italy end-stage renal disease market, 2018 - 2030 (USD Million)
5.8.6 Spain
5.8.6.1 Spain end-stage renal disease market, 2018 - 2030 (USD Million)
5.9 Asia Pacific
5.9.1 Asia Pacific end-stage renal disease Market, 2018 - 2030 (USD Million)
5.9.2 Japan
5.9.2.1 Japan end-stage renal disease market, 2018 - 2030 (USD Million)
5.9.3 China (Mainland)
5.9.3.1 China (Mainland) end-stage renal disease market, 2018 - 2030 (USD Million)
5.9.4 India
5.9.4.1 India end-stage renal disease market, 2018 - 2030 (USD Million)
5.9.5 Australia
5.9.5.1 Australia end-stage renal disease market, 2018 - 2030 (USD Million)
5.9.6 South Korea
5.9.6.1 South Korea end-stage renal disease market, 2018 - 2030 (USD Million)
5.10 Latin America
5.10.1 Latin America end-stage renal disease Market, 2018 - 2030 (USD Million)
5.10.2 Brazil
5.10.2.1 Brazil end-stage renal disease market, 2018 - 2030 (USD Million)
5.10.3 Mexico
5.10.3.1 Mexico end-stage renal disease market, 2018 - 2030 (USD Million)
5.10.4 Argentina
5.10.4.1 Argentina end-stage renal disease market, 2018 - 2030 (USD Million)
5.10.5 Colombia
5.10.5.1 Colombia end-stage renal disease market, 2018 - 2030 (USD Million)
5.11 MEA
5.11.1 MEA end stage renal disease Market, 2018 - 2030 (USD Million)
5.11.2 South Africa
5.11.2.1 South Africa end-stage renal disease market, 2018 - 2030 (USD Million)
5.11.3 Saudi Arabia
5.11.3.1 Saudi Arabia end-stage renal disease market, 2018 - 2030 (USD Million)
5.11.4 UAE
5.11.4.1 UAE end stage renal disease market, 2018 - 2030 (USD Million)

Chapter 6. End Stage Renal Disease Market - Competitive Analysis
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.1.1 Nipro Corporation
6.2 Company Categorization
6.2.1 Innovators
6.2.2 Market Leaders
6.3 Vendor Landscape
6.3.1 Key Customers
6.3.2 Key Company Market Share Analysis, 2021
6.3.3 Major Deals And Strategic Alliances
6.3.3.1 New Product Launch
6.3.3.2 Expansion
6.3.3.3 Acquisition
6.3.3.4 Marketing & Promotions
6.3.4 Market Entry Strategies
6.4 Public Companies
6.4.1 Company Market Position Analysis
6.4.2 Competitive Dashboard Analysis
6.4.2.1 Market Differentiators
6.5 Private Companies
6.5.1 List of Key Emerging Companies
6.5.2 Regional Network Map
6.5.3 Company Market Position Analysis
6.6 Company Profiles
6.6.1 Medtronic
6.6.1.1 Company Overview
6.6.1.2 Financial Performance
6.6.1.3 Product Benchmarking
6.6.1.4 Strategic Initiatives
6.6.2 Fresenius Medical Care AG & Co. KGaA
6.6.2.1 Company Overview
6.6.2.2 Financial Performance
6.6.2.3 Product/Service Benchmarking
6.6.2.4 Strategic Initiatives
6.6.3 B. Braun Melsungen AG
6.6.3.1 Company Overview
6.6.3.2 Financial Performance
6.6.3.3 Product/Service Benchmarking
6.6.4 Baxter International, Inc.
6.6.4.1 Company Overview
6.6.4.2 Financial Performance
6.6.4.3 Product Benchmarking
6.6.4.4 Strategic Initiatives
6.6.5 Asahi Kasei Medical Co., Ltd.
6.6.5.1 Company Overview
6.6.5.2 Financial Performance
6.6.5.3 Product Benchmarking
6.6.5.4 Strategic Initiatives
6.6.6 Cantel Medical
6.6.6.1 Company Overview
6.6.6.2 Financial Performance
6.6.6.3 Product Benchmarking
6.6.6.4 Strategic Initiatives
6.6.7 BD
6.6.7.1 Company Overview
6.6.7.2 Financial Performance
7.6.7.3 Product Benchmarking
6.6.7.4 Strategic Initiatives
6.6.8 Nikkiso Co., Ltd.
6.6.8.1 Company Overview
6.6.8.2 Financial Performance
6.6.8.3 Product Benchmarking
6.6.8.4 Strategic Initiatives
6.6.9 JMS Co. Ltd.
6.6.9.1 Company Overview
6.6.9.2 Financial Performance
6.6.9.3 Product Benchmarking
6.6.9.4 Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America end-stage renal disease market, by country, 2018 - 2030 (USD Million)
Table 4 North America end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 5 U.S end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 6 Canada end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 7 Europe end-stage renal disease market, by country, 2018 - 2030 (USD Million)
Table 8 Europe end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 9 U.K. end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 10 Germany end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 11 France end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 12 Italy end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 13 Spain end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 14 Russia end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 15 Asia Pacific end-stage renal disease market, by country, 2018 - 2030 (USD Million)
Table 16 Asia Pacific end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 17 China end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 18 India end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 19 South Korea end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 20 Australia end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 21 Japan end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 22 Singapore end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 23 Latin America end-stage renal disease market, by country, 2018 - 2030 (USD Million)
Table 24 Latin America end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 25 Brazil end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 26 Mexico end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 27 Argentina end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 28 Colombia end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 29 Middle East & Africa end-stage renal disease market, by country, 2018 - 2030 (USD Million)
Table 30 Middle East & Africa end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 31 South Africa end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 32 South Arabia end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)
Table 33 UAE end-stage renal disease market, by treatment, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 End-stage renal disease market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2021)
Fig. 10 Segment Outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Consumer behavior analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 End Stage Renal Disease market: Treatment movement analysis
Fig. 19 Segment dashboard
Fig. 20 End Stage Renal Disease market treatment outlook: Key takeaways
Fig. 21 Dialysis market, 2018 - 2030 (USD Million)
Fig. 22 Transplantation market, 2018 - 2030 (USD Million)
Fig. 23 End Stage Renal Disease market: End use movement analysis
Fig. 24 Regional outlook, 2021 & 2030
Fig. 25 Regional market dashboard
Fig. 26 Regional market place: Key takeaways
Fig. 27 North America, SWOT, by PEST
Fig. 28 Europe, SWOT, by PEST
Fig. 29 Asia Pacific, SWOT, by PEST
Fig. 30 Latin America, SWOT, by PEST
Fig. 31 Middle East and Africa, SWOT, by PEST
Fig. 32 North America end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 33 U.S. end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 34 Canada end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 35 Europe end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 36 U.K. End Stage Renal Disease market, 2018 - 2030 (USD Million)
Fig. 37 Germany end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 38 France end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 39 Italy end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 40 Spain end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 41 Asia Pacific end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 42 Japan end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 43 China (Mainland) end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 44 India end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 45 Australia end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 46 South Korea end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 47 Latin America end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 48 Brazil end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 49 Mexico end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 50 Argentina end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 51 Colombia end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 52 MEA end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 53 South Africa end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 55 UAE end-stage renal disease market, 2018 - 2030 (USD Million)
Fig. 56 Company market share analysis, 2021
Fig. 57 Strategy mapping
Fig. 58 Market differentiators
Fig. 59 Regional network map